NeoPharm (Korea) Price History

092730 Stock  KRW 12,000  90.00  0.74%   
If you're considering investing in NeoPharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of NeoPharm stands at 12,000, as last reported on the 18th of December 2024, with the highest price reaching 12,030 and the lowest price hitting 11,790 during the day. At this point, NeoPharm is very steady. NeoPharm LTD has Sharpe Ratio of 0.0537, which conveys that the firm had a 0.0537% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for NeoPharm, which you can use to evaluate the volatility of the firm. Please verify NeoPharm's Downside Deviation of 2.78, mean deviation of 2.23, and Risk Adjusted Performance of 0.0591 to check out if the risk estimate we provide is consistent with the expected return of 0.15%.
  
NeoPharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0537

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns092730
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.84
  actual daily
25
75% of assets are more volatile

Expected Return

 0.15
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
4
96% of assets perform better
Based on monthly moving average NeoPharm is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NeoPharm by adding it to a well-diversified portfolio.

NeoPharm Stock Price History Chart

There are several ways to analyze NeoPharm Stock price data. The simplest method is using a basic NeoPharm candlestick price chart, which shows NeoPharm price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 6, 202414620.0
Lowest PriceDecember 9, 202411090.0

NeoPharm December 18, 2024 Stock Price Synopsis

Various analyses of NeoPharm's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NeoPharm Stock. It can be used to describe the percentage change in the price of NeoPharm from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NeoPharm Stock.
NeoPharm Market Facilitation Index 0.01 
NeoPharm Accumulation Distribution 807.84 
NeoPharm Price Rate Of Daily Change 0.99 
NeoPharm Price Action Indicator 45.00 
NeoPharm Price Daily Balance Of Power(0.37)

NeoPharm December 18, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in NeoPharm Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use NeoPharm intraday prices and daily technical indicators to check the level of noise trading in NeoPharm Stock and then apply it to test your longer-term investment strategies against NeoPharm.

NeoPharm Stock Price History Data

The price series of NeoPharm for the period between Thu, Sep 19, 2024 and Wed, Dec 18, 2024 has a statistical range of 3870.0 with a coefficient of variation of 6.8. The prices are distributed with arithmetic mean of 12496.36. The median price for the last 90 days is 12500.0. The company had 1:2 stock split on 18th of September 2024.
OpenHighLowCloseVolume
12/18/2024 12,000  12,030  11,790  12,000  40,493 
12/17/2024 12,010  12,160  11,910  12,000  28,832 
12/16/2024 12,140  12,280  11,950  12,090  55,398 
12/13/2024 11,940  12,060  11,770  11,950  41,243 
12/12/2024 11,880  12,200  11,850  11,940  33,407 
12/11/2024 11,590  12,050  11,230  11,850  51,583 
12/10/2024 11,130  11,710  11,110  11,590  49,729 
12/09/2024 11,310  11,430  11,000  11,090  130,138 
12/06/2024 11,880  11,880  11,390  11,600  88,698 
12/05/2024 11,860  12,000  11,600  11,890  66,639 
12/04/2024 11,800  12,160  11,300  12,000  53,686 
12/03/2024 11,730  12,390  11,730  12,040  74,606 
12/02/2024 11,980  12,050  11,650  11,730  49,156 
11/29/2024 12,280  12,280  11,310  12,100  53,440 
11/28/2024 12,210  12,460  12,180  12,280  55,216 
11/27/2024 12,270  12,880  12,100  12,400  139,907 
11/26/2024 12,000  12,400  11,810  12,400  88,518 
11/25/2024 11,580  12,040  11,440  12,000  145,589 
11/22/2024 11,650  11,990  11,360  11,580  167,049 
11/21/2024 12,000  12,000  11,710  11,840  32,758 
11/20/2024 12,160  12,160  11,790  11,840  100,463 
11/19/2024 12,880  12,890  12,360  12,370  55,505 
11/18/2024 12,940  13,270  12,600  12,890  33,164 
11/15/2024 13,120  13,480  12,820  13,070  19,054 
11/14/2024 12,960  13,200  12,800  13,010  36,047 
11/13/2024 12,520  13,040  12,360  13,020  70,973 
11/12/2024 13,570  13,900  12,690  12,850  69,615 
11/11/2024 14,380  14,380  13,510  13,570  41,211 
11/08/2024 14,110  14,400  14,050  14,050  36,783 
11/07/2024 14,710  14,930  13,960  14,100  143,587 
11/06/2024 14,230  14,850  14,100  14,620  145,956 
11/05/2024 14,360  14,430  13,900  14,230  64,355 
11/04/2024 13,730  15,100  13,700  14,150  269,008 
11/01/2024 12,920  13,410  12,510  13,200  64,267 
10/31/2024 13,400  13,400  12,830  12,920  59,582 
10/30/2024 13,570  13,850  13,010  13,400  112,652 
10/29/2024 13,375  13,400  12,950  13,250  229,638 
10/28/2024 13,300  13,550  13,100  13,400  160,180 
10/25/2024 13,750  13,850  13,300  13,450  150,874 
10/24/2024 13,350  13,750  13,150  13,675  175,206 
10/23/2024 13,000  13,425  12,650  13,350  215,782 
10/22/2024 12,625  13,100  12,425  12,875  107,488 
10/21/2024 12,650  12,925  12,525  12,750  68,778 
10/18/2024 13,175  13,175  12,500  12,600  105,934 
10/17/2024 13,225  13,325  12,675  12,950  154,096 
10/16/2024 13,375  13,850  13,050  13,150  517,502 
10/15/2024 12,750  12,850  12,400  12,825  51,374 
10/14/2024 12,400  12,625  12,300  12,500  52,504 
10/11/2024 12,775  12,775  12,300  12,500  79,156 
10/10/2024 12,250  12,850  12,250  12,650  107,570 
10/08/2024 12,800  12,800  12,225  12,225  66,420 
10/07/2024 12,850  12,950  12,300  12,800  99,850 
10/04/2024 12,600  12,825  12,000  12,650  181,844 
10/02/2024 13,100  13,475  12,350  12,600  216,232 
09/30/2024 13,175  13,825  12,975  13,200  253,466 
09/27/2024 12,350  13,325  12,325  13,175  333,668 
09/26/2024 11,525  12,475  11,475  12,475  255,324 
09/25/2024 11,350  11,925  11,250  11,550  134,888 
09/24/2024 11,475  11,500  11,200  11,250  45,186 
09/23/2024 11,275  11,450  11,100  11,450  53,036 
09/20/2024 11,225  11,500  11,125  11,275  96,180 

About NeoPharm Stock history

NeoPharm investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NeoPharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NeoPharm LTD will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NeoPharm stock prices may prove useful in developing a viable investing in NeoPharm
,Ltd. manufactures and sells skin care products in Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Daejeon, South Korea. Neopharm is traded on Korean Securities Dealers Automated Quotations in South Korea.

NeoPharm Stock Technical Analysis

NeoPharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NeoPharm technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NeoPharm trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

NeoPharm Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NeoPharm's price direction in advance. Along with the technical and fundamental analysis of NeoPharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NeoPharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for NeoPharm Stock analysis

When running NeoPharm's price analysis, check to measure NeoPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeoPharm is operating at the current time. Most of NeoPharm's value examination focuses on studying past and present price action to predict the probability of NeoPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeoPharm's price. Additionally, you may evaluate how the addition of NeoPharm to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements